Michael Byrnes insider trades

Open-market stock purchases and sales by Michael Byrnes, Director at Cero Therapeutics Holdings, Inc, from SEC Form 4 filings since Oct 1, 2014.

Recent trades

DateStockTradeValue
Jan 7, 2026CERO Cero Therapeutics Holdings, IncBought (not open market)—

Companies traded

  • CERO Cero Therapeutics Holdings, Inc: other filings, last Jan 7, 2026
  • EFTR eFFECTOR Therapeutics, Inc: 1 buy, last May 15, 2024
  • OCRX Ocera Therapeutics, Inc: 4 buys, last Dec 11, 2017

Get free alerts when Michael Byrnes files a new trade →